HLA-DRB1 and rheumatoid arthritis: Despite the fluctuations observed in the HLA-DRB1*04:04, studies have demonstrated that citrullinated peptides presented by this molecule in RA patients provoke strong responses by CD4+ T cells, whose antigen-specific frequencies strongly correlate with disease activity [27].